# Vishay Precision Group, Inc.: financial statements, quarterly

VPG · NYSE · CIK 1487952 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vpg.md) · [Financials](/companies/vpg/financials.md) · [Filings](/companies/vpg/filings.md) · [Insiders](/companies/vpg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vpg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [85.9](/filings/0001487952-24-000059.md) | [89.5 d](/filings/0001437749-26-005982.md) | [80.8](/filings/0001487952-25-000041.md) | [77.4](/filings/0001437749-25-024734.md) | [75.7](/filings/0001437749-25-032882.md) | [72.7 d](/filings/0001437749-26-005982.md) | [71.7](/filings/0001437749-26-016261.md) | [75.2](/filings/0001437749-26-025797.md) | [79.7](/filings/0001437749-25-032882.md) | [80.6 d](/filings/0001437749-26-005982.md) | [84.4](/filings/0001437749-26-016261.md) | [83.9](/filings/0001437749-26-025797.md) |
| Cost of revenue | $m | [49.9](/filings/0001487952-24-000059.md) | [51.0 d](/filings/0001437749-26-005982.md) | [45.7](/filings/0001487952-25-000041.md) | [45.0](/filings/0001437749-25-024734.md) | [45.5](/filings/0001437749-25-032882.md) | [44.9 d](/filings/0001437749-26-005982.md) | [44.7](/filings/0001437749-26-016261.md) | [44.6](/filings/0001437749-26-025797.md) | [47.6](/filings/0001437749-25-032882.md) | [50.9 d](/filings/0001437749-26-005982.md) | [51.5](/filings/0001437749-26-016261.md) | [51.5](/filings/0001437749-26-025797.md) |
| Gross profit | $m | [35.9](/filings/0001487952-24-000059.md) | [38.5 d](/filings/0001437749-26-005982.md) | [35.1](/filings/0001487952-25-000041.md) | [32.4](/filings/0001437749-25-024734.md) | [30.3](/filings/0001437749-25-032882.md) | [27.8 d](/filings/0001437749-26-005982.md) | [27.0](/filings/0001437749-26-016261.md) | [30.6](/filings/0001437749-26-025797.md) | [32.1](/filings/0001437749-25-032882.md) | [29.7 d](/filings/0001437749-26-005982.md) | [32.9](/filings/0001437749-26-016261.md) | [32.4](/filings/0001437749-26-025797.md) |
| Research and development | $m | not reported | not reported | [4.9](/filings/0001487952-25-000041.md) | [4.9](/filings/0001437749-25-024734.md) | [4.9](/filings/0001437749-25-032882.md) | [5.3 d](/filings/0001437749-26-005982.md) | [4.9](/filings/0001437749-26-016261.md) | [5.4](/filings/0001437749-26-025797.md) | [5.0](/filings/0001437749-25-032882.md) | [5.5 d](/filings/0001437749-26-005982.md) | [5.6](/filings/0001437749-26-016261.md) | [5.8](/filings/0001437749-26-025797.md) |
| Selling, general and administrative | $m | [26.6](/filings/0001487952-24-000059.md) | [26.4 d](/filings/0001437749-26-005982.md) | [27.4](/filings/0001487952-25-000041.md) | [26.5](/filings/0001437749-25-024734.md) | [26.3](/filings/0001437749-25-032882.md) | [27.3 d](/filings/0001437749-26-005982.md) | [26.7](/filings/0001437749-26-016261.md) | [27.7](/filings/0001437749-26-025797.md) | [27.3](/filings/0001437749-25-032882.md) | [27.9 d](/filings/0001437749-26-005982.md) | [32.1](/filings/0001437749-26-016261.md) | [32.0](/filings/0001437749-26-025797.md) |
| Operating income | $m | [8.2](/filings/0001487952-24-000059.md) | [12.0 d](/filings/0001437749-26-005982.md) | [6.9](/filings/0001487952-25-000041.md) | [5.9](/filings/0001437749-25-024734.md) | [3.8](/filings/0001437749-25-032882.md) | [0.2 d](/filings/0001437749-26-005982.md) | [(0.1)](/filings/0001437749-26-016261.md) | [2.7](/filings/0001437749-26-025797.md) | [10.2](/filings/0001437749-25-032882.md) | [1.0 d](/filings/0001437749-26-005982.md) | [0.3](/filings/0001437749-26-016261.md) | [(0.3)](/filings/0001437749-26-025797.md) |
| Interest expense | $m | [1.1](/filings/0001487952-23-000047.md) | [0.8 d](/filings/0001487952-24-000006.md) | [0.6](/filings/0001487952-24-000030.md) | [0.6](/filings/0001437749-25-024734.md) | [0.6](/filings/0001437749-25-032882.md) | [0.6 d](/filings/0001437749-26-005982.md) | [0.6](/filings/0001437749-26-016261.md) | [0.6](/filings/0001437749-26-025797.md) | [0.4](/filings/0001437749-25-032882.md) | [0.4 d](/filings/0001437749-26-005982.md) | [0.3](/filings/0001437749-26-016261.md) | [0.3](/filings/0001437749-26-025797.md) |
| Income tax | $m | [2.4](/filings/0001487952-24-000059.md) | [4.4 d](/filings/0001437749-26-005982.md) | [2.3](/filings/0001487952-25-000041.md) | [2.3](/filings/0001437749-25-024734.md) | [1.9](/filings/0001437749-25-032882.md) | [1.2 d](/filings/0001437749-26-005982.md) | [(0.3)](/filings/0001437749-26-016261.md) | [0.6](/filings/0001437749-26-025797.md) | [2.0](/filings/0001437749-25-032882.md) | [1.2 d](/filings/0001437749-26-005982.md) | [0.1](/filings/0001437749-26-016261.md) | [(0.1)](/filings/0001437749-26-025797.md) |
| Net income | $m | [6.3](/filings/0001487952-24-000059.md) | [4.2 d](/filings/0001437749-26-005982.md) | [5.9](/filings/0001487952-25-000041.md) | [4.6](/filings/0001437749-25-024734.md) | [(1.4)](/filings/0001437749-25-032882.md) | [0.8 d](/filings/0001437749-26-005982.md) | [(0.9)](/filings/0001437749-26-016261.md) | [0.2](/filings/0001437749-26-025797.md) | [7.9](/filings/0001437749-25-032882.md) | [(1.9) d](/filings/0001437749-26-005982.md) | [(0.3)](/filings/0001437749-26-016261.md) | [(1.7)](/filings/0001437749-26-025797.md) |
| Diluted EPS | $ per share | [0.46](/filings/0001487952-24-000059.md) | not reported | [0.44](/filings/0001487952-25-000041.md) | [0.34](/filings/0001437749-25-024734.md) | [(0.10)](/filings/0001437749-25-032882.md) | not reported | [(0.07)](/filings/0001437749-26-016261.md) | [0.02](/filings/0001437749-26-025797.md) | [0.59](/filings/0001437749-25-032882.md) | not reported | [(0.02)](/filings/0001437749-26-016261.md) | [(0.13)](/filings/0001437749-26-025797.md) |
| Basic EPS | $ per share | [0.46](/filings/0001487952-24-000059.md) | not reported | [0.44](/filings/0001487952-25-000041.md) | [0.34](/filings/0001437749-25-024734.md) | [(0.10)](/filings/0001437749-25-032882.md) | not reported | [(0.07)](/filings/0001437749-26-016261.md) | [0.02](/filings/0001437749-26-025797.md) | [0.59](/filings/0001437749-25-032882.md) | not reported | [(0.02)](/filings/0001437749-26-016261.md) | [(0.13)](/filings/0001437749-26-025797.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [84.0](/filings/0001487952-24-000006.md) | not reported | not reported | not reported | [79.3](/filings/0001437749-26-005982.md) | not reported | [90.4](/filings/0001437749-25-024734.md) | [86.3](/filings/0001437749-25-032882.md) | [87.4](/filings/0001437749-26-025797.md) | [82.5](/filings/0001437749-26-016261.md) | [75.7](/filings/0001437749-26-025797.md) |
| Current assets | $m | [260](/filings/0001487952-23-000047.md) | [243](/filings/0001487952-25-000014.md) | [241](/filings/0001487952-24-000030.md) | [241](/filings/0001487952-24-000043.md) | [242](/filings/0001487952-24-000059.md) | [237](/filings/0001437749-26-005982.md) | [241](/filings/0001487952-25-000041.md) | [253](/filings/0001437749-25-024734.md) | [252](/filings/0001437749-25-032882.md) | [247](/filings/0001437749-26-025797.md) | [246](/filings/0001437749-26-016261.md) | [244](/filings/0001437749-26-025797.md) |
| Total assets | $m | [484](/filings/0001487952-23-000047.md) | [472](/filings/0001487952-25-000014.md) | [466](/filings/0001487952-24-000030.md) | [463](/filings/0001487952-24-000043.md) | [463](/filings/0001487952-24-000059.md) | [451](/filings/0001437749-26-005982.md) | [454](/filings/0001487952-25-000041.md) | [466](/filings/0001437749-25-024734.md) | [462](/filings/0001437749-25-032882.md) | [456](/filings/0001437749-26-025797.md) | [454](/filings/0001437749-26-016261.md) | [451](/filings/0001437749-26-025797.md) |
| Current liabilities | $m | [59.7](/filings/0001487952-23-000047.md) | [61.6](/filings/0001487952-25-000014.md) | [91.5](/filings/0001487952-24-000030.md) | [90.2](/filings/0001487952-24-000043.md) | [55.0](/filings/0001487952-24-000059.md) | [53.0](/filings/0001437749-26-005982.md) | [53.5](/filings/0001487952-25-000041.md) | [58.1](/filings/0001437749-25-024734.md) | [61.5](/filings/0001437749-25-032882.md) | [55.3](/filings/0001437749-26-025797.md) | [55.0](/filings/0001437749-26-016261.md) | [58.8](/filings/0001437749-26-025797.md) |
| Total liabilities | $m | [160](/filings/0001487952-23-000047.md) | [142](/filings/0001487952-25-000014.md) | [138](/filings/0001487952-24-000030.md) | [136](/filings/0001487952-24-000043.md) | [132](/filings/0001487952-24-000059.md) | [129](/filings/0001437749-26-005982.md) | [129](/filings/0001487952-25-000041.md) | [134](/filings/0001437749-25-024734.md) | [125](/filings/0001437749-25-032882.md) | [120](/filings/0001437749-26-025797.md) | [119](/filings/0001437749-26-016261.md) | [118](/filings/0001437749-26-025797.md) |
| Long-term debt | $m | [53.8](/filings/0001487952-23-000047.md) | [31.9](/filings/0001487952-25-000014.md) | [0.0](/filings/0001487952-24-000030.md) | [0.0](/filings/0001487952-24-000043.md) | [31.4](/filings/0001487952-24-000059.md) | [31.4](/filings/0001437749-26-005982.md) | [31.5](/filings/0001487952-25-000041.md) | [31.5](/filings/0001437749-25-024734.md) | [20.6](/filings/0001437749-25-032882.md) | [20.6](/filings/0001437749-26-025797.md) | [20.6](/filings/0001437749-26-016261.md) | [15.6](/filings/0001437749-26-025797.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001487952-24-000043.md) | [31.9](/filings/0001487952-24-000030.md) | [31.9](/filings/0001487952-24-000043.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [324](/filings/0001487952-23-000047.md) | [330](/filings/0001487952-25-000014.md) | [328](/filings/0001487952-24-000030.md) | [327](/filings/0001487952-24-000043.md) | [331](/filings/0001487952-24-000059.md) | [322](/filings/0001437749-26-005982.md) | [325](/filings/0001487952-25-000041.md) | [331](/filings/0001437749-25-024734.md) | [338](/filings/0001437749-25-032882.md) | [336](/filings/0001437749-26-025797.md) | [335](/filings/0001437749-26-016261.md) | [333](/filings/0001437749-26-025797.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.9 d](/filings/0001487952-24-000059.md) | [18.8 d](/filings/0001437749-26-005982.md) | [6.4](/filings/0001487952-25-000041.md) | [7.5 d](/filings/0001437749-25-024734.md) | [(0.8) d](/filings/0001437749-25-032882.md) | [6.8 d](/filings/0001437749-26-005982.md) | [5.2](/filings/0001437749-26-016261.md) | [6.0 d](/filings/0001437749-26-025797.md) | [(1.3) d](/filings/0001437749-25-032882.md) | [4.4 d](/filings/0001437749-26-005982.md) | [(0.6)](/filings/0001437749-26-016261.md) | [0.3 d](/filings/0001437749-26-025797.md) |
| Capital expenditure | $m | [3.0 d](/filings/0001487952-24-000059.md) | [5.3 d](/filings/0001437749-26-005982.md) | [2.6](/filings/0001487952-25-000041.md) | [2.6 d](/filings/0001437749-25-024734.md) | [1.8 d](/filings/0001437749-25-032882.md) | [2.2 d](/filings/0001437749-26-005982.md) | [1.5](/filings/0001437749-26-016261.md) | [1.3 d](/filings/0001437749-26-025797.md) | [2.2 d](/filings/0001437749-25-032882.md) | [3.1 d](/filings/0001437749-26-005982.md) | [3.1](/filings/0001437749-26-016261.md) | [2.0 d](/filings/0001437749-26-025797.md) |
| Share repurchases | $m | [0.8 d](/filings/0001487952-24-000059.md) | [4.7 d](/filings/0001437749-26-005982.md) | [2.8](/filings/0001487952-25-000041.md) | [3.1 d](/filings/0001437749-25-024734.md) | [1.9 d](/filings/0001437749-25-032882.md) | [0.0 d](/filings/0001437749-26-005982.md) | [0.0](/filings/0001487952-25-000041.md) | [0.0 d](/filings/0001437749-25-024734.md) | [0.0 d](/filings/0001437749-25-032882.md) | [0.0 d](/filings/0001437749-26-005982.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.7](/filings/0001487952-23-000047.md) | [13.7](/filings/0001487952-24-000030.md) | [13.7](/filings/0001487952-24-000043.md) | [13.7](/filings/0001487952-24-000059.md) | [13.5](/filings/0001487952-25-000041.md) | [13.4](/filings/0001437749-25-024734.md) | [13.3](/filings/0001437749-25-032882.md) | [0.0](/filings/0001437749-26-016261.md) | [0.0](/filings/0001437749-26-025797.md) | [13.3](/filings/0001437749-25-032882.md) | [0.0](/filings/0001437749-26-016261.md) | [0.0](/filings/0001437749-26-025797.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,256,197 at 2025-11-04, from the cover of the [10-Q filed 2025-11-04](/filings/0001437749-25-032882.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.